These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31377347)

  • 1. The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer.
    Le Corre D; Ghazi A; Balogoun R; Pilati C; Aparicio T; Martin-Lannerée S; Marisa L; Djouadi F; Poindessous V; Crozet C; Emile JF; Mulot C; Le Malicot K; Boige V; Blons H; de Reynies A; Taieb J; Ghiringhelli F; Bennouna J; Launay JM; Laurent-Puig P; Mouillet-Richard S
    EBioMedicine; 2019 Aug; 46():94-104. PubMed ID: 31377347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.
    Mouillet-Richard S; Gougelet A; Passet B; Brochard C; Le Corre D; Pitasi CL; Joubel C; Sroussi M; Gallois C; Lavergne J; Castille J; Vilotte M; Daniel-Carlier N; Pilati C; de Reyniès A; Djouadi F; Colnot S; André T; Taieb J; Vilotte JL; Romagnolo B; Laurent-Puig P
    J Transl Med; 2024 Apr; 22(1):337. PubMed ID: 38589873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the PrP
    Ghazi A; Le Corre D; Pilati C; Taieb J; Aparicio T; Didelot A; Dedhar S; Mulot C; Le Malicot K; Djouadi F; de Reynies A; Launay JM; Laurent-Puig P; Mouillet-Richard S
    Oncoimmunology; 2021; 10(1):1940674. PubMed ID: 34249475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
    Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
    Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype.
    Huang Y; Wang G; Zhao C; Geng R; Zhang S; Wang W; Chen J; Liu H; Wang X
    Dis Markers; 2019; 2019():5231269. PubMed ID: 30956730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    Irshad S; Bansal M; Guarnieri P; Davis H; Al Haj Zen A; Baran B; Pinna CMA; Rahman H; Biswas S; Bardella C; Jeffery R; Wang LM; East JE; Tomlinson I; Lewis A; Leedham SJ
    J Pathol; 2017 Jun; 242(2):178-192. PubMed ID: 28299802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells.
    de Lacerda TC; Costa-Silva B; Giudice FS; Dias MV; de Oliveira GP; Teixeira BL; Dos Santos TG; Martins VR
    Clin Exp Metastasis; 2016 Jun; 33(5):441-51. PubMed ID: 27112151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
    Gao T; Wang M; Xu L; Wen T; Liu J; An G
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.
    Fessler E; Jansen M; De Sousa E Melo F; Zhao L; Prasetyanti PR; Rodermond H; Kandimalla R; Linnekamp JF; Franitza M; van Hooff SR; de Jong JH; Oppeneer SC; van Noesel CJ; Dekker E; Stassi G; Wang X; Medema JP; Vermeulen L
    Oncogene; 2016 Nov; 35(46):6026-6037. PubMed ID: 27157610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
    Gargalionis AN; Korkolopoulou P; Farmaki E; Piperi C; Dalagiorgou G; Adamopoulos C; Levidou G; Saetta A; Fragkou P; Tsioli P; Kiaris H; Zizi-Serbetzoglou A; Karavokyros I; Papavassiliou KA; Tsavaris N; Patsouris E; Basdra EK; Papavassiliou AG
    Int J Cancer; 2015 Apr; 136(7):1515-27. PubMed ID: 25123959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
    Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
    EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of plastin-3 via copy number gain induces the epithelial-mesenchymal transition in circulating colorectal cancer cells.
    Sugimachi K; Yokobori T; Iinuma H; Ueda M; Ueo H; Shinden Y; Eguchi H; Sudo T; Suzuki A; Maehara Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Oct; 21(11):3680-90. PubMed ID: 24217791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer.
    Matsuyama T; Ishikawa T; Takahashi N; Yamada Y; Yasuno M; Kawano T; Uetake H; Goel A
    Mol Cancer; 2019 Feb; 18(1):19. PubMed ID: 30717807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancer.
    Antonacopoulou AG; Palli M; Marousi S; Dimitrakopoulos FI; Kyriakopoulou U; Tsamandas AC; Scopa CD; Papavassiliou AG; Kalofonos HP
    Mol Carcinog; 2010 Jul; 49(7):693-9. PubMed ID: 20564346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.
    Lee JH; Han YS; Yoon YM; Yun CW; Yun SP; Kim SM; Kwon HY; Jeong D; Baek MJ; Lee HJ; Lee SJ; Han HJ; Lee SH
    Oncogene; 2017 Nov; 36(47):6555-6567. PubMed ID: 28759037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.